Björn Stollenwerk

Assessing The Cost-Utility of Etelcalcetide: A Markov Model

Sergio Iannazzo, Andrew Briggs, Ron Akehurst, 2016 .

Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach

Thomas Welchowski, Björn Stollenwerk, Stephanie Stock, 2016, The European Journal of Health Economics.

Costs and effects of intra-operative fluorescence molecular imaging – A model-based, early assessment

Reiner Leidl, Maximilian Präger, Jürgen Glatz, 2018, PloS one.